Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
Completed · Phase 3 · Has a placebo group
Conditions studied: Idiopathic Pulmonary Fibrosis, Cough
In brief
Idiopathic Pulmonary Fibrosis (IPF) is a rapidly progressive lung disorder that is often associated with a chronic, intractable cough. The etiology of the cough associated with IPF is unclear but it is often so severe that it adversely effects the patient's quality of life. We propose that thalidomide specifically suppresses the cough associated with idiopathic pulmonary fibrosis via its anti-inflammatory properties, by suppressing the excessive functional up-regulation of sensory fibers with in the respiratory tract of patients with IPF. This study is a Phase III, double blinded, randomized, placebo controlled, crossover trial testing the efficacy of thalidomide in suppressing the chronic cough of IPF. The primary objective of this study is to determine the efficacy of thalidomide administered daily for 12 weeks to suppress the chronic cough in patients with idiopathic pulmonary fibrosis as measured by cough specific questionnaires, scales and improved quality of life.
Key facts
- Study ID
- NCT00600028
- Run by
- Johns Hopkins University
- People needed
- 25
- Starts
- 2007-12-01
- Expected to finish
- 2011-09-01
- Last updated by the study team
- 2017-05-15
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Idiopathic pulmonary fibrosis for >3 months <5 years
- High resolution CT scan of chest consistent with IPF within the previous 12 months
- FVC > 40% and < 90% predicted, TLC >40% <80%, DLCo >30% <90%
- Chronic Cough - cough >8 weeks
- Age >50
- Non-child bearing potential
You may not qualify if…
- Pregnant or lactating women
- Women of child bearing potential
- Known etiology of lung fibrosis other than IPF
- Significant respiratory toxin exposure
- Collagen Vascular Disease
- Use of narcotic anti-cough agent in last week
- significant peripheral vascular disease or neuropathy
- history of seizures
- poorly controlled diabetes
- allergy to thalidomide
Where it is running
- Johns Hopkins Bayview Medical Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.